We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $722M
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
+15.89%
1 Year Est. Return
+97.69%
3 Year Est. Return
+317.96%
5 Year Est. Return
+499.45%
10 Year Est. Return
+3,067.75%
AUM
$1.34B
AUM Growth
+$347M
Cap. Flow
+$259M
Cap. Flow %
19.39%
Top 10 Hldgs %
42.27%
Holding
106
New
20
Increased
24
Reduced
18
Closed
17

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$21.6M
2
ORCL icon
Oracle
ORCL
+$19.1M
3
APP icon
Applovin
APP
+$18.6M
4
IOT icon
Samsara
IOT
+$13.1M
5
FTAI icon
FTAI Aviation
FTAI
+$12.8M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$13.9M
2
NEM icon
Newmont
NEM
+$9.92M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$8.36M
4
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$7.94M
5
TECK icon
Teck Resources
TECK
+$7.51M

Sector Composition

Rank Sector Weight
1 Technology 39.85%
2 Industrials 9.68%
3 Healthcare 8.73%
4 Communication Services 7.71%
5 Financials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PR
76
Permian Resources
PR
$16.9B
$2.25M 0.17%
156,344
– –
PLGO
77
Pelagos Insurance Capital
PLGO
$2.14B
$2.07M 0.15%
114,000
– –
MED icon
78
Medifast
MED
$141M
$1.98M 0.15%
112,400
– –
NBIS
79
Nebius Group N.V.
NBIS
$47.7B
$1.87M 0.14%
+67,500
New +$1.65M
ASML icon
80
ASML
ASML
$669B
$1.82M 0.14%
2,623
-5,250
-67% -$3.77M
BYND icon
81
Beyond Meat
BYND
$277M
$1.75M 0.13%
+464,372
New +$2.47M
SG icon
82
Sweetgreen
SG
$642M
$1.64M 0.12%
51,200
-42,700
-45% -$1.59M
ROIV icon
83
Roivant Sciences
ROIV
$26.2B
$1.18M 0.09%
+99,500
New +$1.18M
CFLT
84
DELISTED
Confluent
CFLT
$1.15M 0.09%
+41,000
New +$1.1M
OIH icon
85
VanEck Oil Services ETF
OIH
$1.84B
$1.06M 0.08%
3,900
-4,200
-52% -$1.21M
UPST icon
86
Upstart Holdings
UPST
$3.03B
$1M 0.08%
16,319
– –
NKE icon
87
Nike
NKE
$61.9B
$586K 0.04%
7,748
– –
ARQT icon
88
Arcutis Biotherapeutics
ARQT
$3.18B
$578K 0.04%
+41,500
New +$455K
HRTX icon
89
Heron Therapeutics
HRTX
$92.9M
$197K 0.01%
128,592
– –
ARM icon
90
Arm
ARM
$302B
– –
-10,092
Closed -$1.44M
BABA icon
91
Alibaba
BABA
$308B
– –
-61,500
Closed -$6.53M
FXI icon
92
CALL
iShares China Large-Cap ETF
FXI
$4.31B
– –
-140,000
Closed -$4.45M
FXI icon
93
iShares China Large-Cap ETF
FXI
$4.31B
– –
-263,200
Closed -$8.36M
KEYS icon
94
Keysight
KEYS
$58.3B
– –
-3,893
Closed -$619K
KGC icon
95
Kinross Gold
KGC
$32.8B
– –
-180,000
Closed -$1.68M
KWEB icon
96
KraneShares CSI China Internet ETF
KWEB
$5.67B
– –
-233,500
Closed -$7.94M
LYFT icon
97
Lyft
LYFT
$6.63B
– –
-78,380
Closed -$999K
NEM icon
98
Newmont
NEM
$119B
– –
-185,600
Closed -$9.92M
NVT icon
99
nVent Electric
NVT
$26.7B
– –
-56,000
Closed -$3.93M
RUN icon
100
Sunrun
RUN
$2.46B
– –
-11,801
Closed -$213K
1 2 3
4
5

Similar funds

FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

Zweig-DiMenna Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Zweig-DiMenna Associates held 106 positions worth $1.34B, up 35% from $990M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Zweig-DiMenna Associates deployed $259M of net new capital in Q4 2024, opening 20 new positions and adding to 24 existing holdings. Its largest new stake was GeneDx Holdings: 309,500 shares worth $23.8M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 43% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $13.9M trimmed.

  • Zweig-DiMenna Associates's largest Q4 2024 buy was GeneDx Holdings: 309,500 shares worth $23.8M.
  • Zweig-DiMenna Associates added most to Samsara in Q4 2024, an estimated $13.1M increase.
  • Zweig-DiMenna Associates's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $13.9M.
  • Zweig-DiMenna Associates fully exited Newmont in Q4 2024, selling an estimated $9.92M.
  • Zweig-DiMenna Associates's ten largest holdings make up 42% of its $1.34B portfolio in Q4 2024.
  • Zweig-DiMenna Associates opened 20 new positions and closed 17 in Q4 2024.
  • Zweig-DiMenna Associates's portfolio value rose 35% quarter-over-quarter to $1.34B.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2024, filed 21 Jan 2025.